2017 Press Releases
12-21-2017 ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock
12-19-2017 ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
11-13-2017 ImmuCell Announces Financial Results for Third Quarter of 2017
11-13-2017 ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections
11-07-2017 ImmuCell Announces Completion of Construction of Nisin Production Facility
11-02-2017 ImmuCell to Announce Financial Results for Third Quarter of 2017
09-13-17 ImmuCell Announces Expansion of Sales and Marketing Team
08-14-2017 ImmuCell Announces Financial Results for Second Quarter of 2017
08-07-2017 ImmuCell to Announce Financial Results for Second Quarter of 2017
07-27-2017 ImmuCell Closes $1,000,000 Equity Investment
07-17-2017 ImmuCell Unveils New Website
07-13-2017 ImmuCell Clarifies Number of Authorized Common Shares
05-11-2017 ImmuCell Announces Financial Results for First Quarter of 2017
05-04-2017 ImmuCell to Announce Financial Results for First Quarter of 2017
03-08-2017 Bobbi Jo Brockmann is appointed to Board of Directors of ImmuCell Corporation
03-02-2017 ImmuCell Secures $2 Million in Debt Financing
02-09-2017 ImmuCell Announces Preliminary 2016 Financial Results
02-06-2017 ImmuCell to Announce Preliminary 2016 Financial Results